[Federal Register Volume 81, Number 10 (Friday, January 15, 2016)]
[Notices]
[Pages 2237-2238]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-00782]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Cambridge 
Isotope Lab

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Cambridge Isotope Lab applied to be registered as a

[[Page 2238]]

manufacturer of a certain basic class of controlled substance. The Drug 
Enforcement Administration (DEA) grants Cambridge Isotope Lab 
registration as a manufacturer of this controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated October 2, 2015, and 
published in the Federal Register on October 13, 2015, 80 FR 61470, 
Cambridge Isotope Lab, 50 Frontage Road, Andover, Massachusetts 01810 
applied to be registered as a manufacturer of a certain basic class of 
controlled substance. No comments or objections were submitted for this 
notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of Cambridge Isotope Lab to 
manufacture the basic class of controlled substance is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of morphine (9300), a basic class of controlled substance 
listed in schedule II.
    The company plans to utilize small quantities of the listed 
controlled substance in the preparation of analytical standards.

    Dated: January 11, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-00782 Filed 1-14-16; 8:45 am]
 BILLING CODE 4410-09-P